TY - JOUR T1 - Fecal genomic DNA extraction method impacts outcome of MinION based metagenome profile of tuberculosis patients JF - medRxiv DO - 10.1101/2021.11.15.21266154 SP - 2021.11.15.21266154 AU - Sukanya Sahu AU - Sandeep Rai Kaushik AU - Bidhan Goswami AU - Arunabha Dasgupta AU - Hritusree Guha AU - Ranjit Das AU - Sourav Saha AU - Anjan Das AU - Ranjan Kumar Nanda Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/11/15/2021.11.15.21266154.abstract N2 - In the present era, emergence of next generation sequencing approaches has revolutionized the field of gut microbiome study. However, the adopted DNA extraction step used in metagenomics experiments and its efficiency may play a critical role in their reproducibility and outcome. In this study, fecal samples from active and non-tuberculosis subjects (ATB/NTB, n=7) were used. Fecal samples of a subgroup of these subjects were subjected to Mechanical enzymatic lysis (MEL) and Phenol: Chloroform: Isoamyl Alcohol (PCIA) methods of DNA extraction and a third-generation sequencing platform i.e. MinION was employed for microbiome profiling. Findings of this study demonstrated that DNA extraction method significantly impacts the DNA yield and microbial diversity. Irrespective of the adopted method of DNA extraction, ATB patients showed altered microbial diversity compared to NTB controls. Also, the fecal microbial diversity details are better captured in samples processed by MEL method and may be suitable to be adopted for high-throughput gut microbiome studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding from Department of Biotechnology (DBT), Government of India for supporting activities through research grant (MDR-TB/2017/39) and core support from International Centre for Genetic Engineering and Biotechnology, New Delhi to RKN is highly acknowledged.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is part of an ongoing project approved by the Institute Human Ethics Committees of the Agartala Government Medical College, Agartala (protocolF.4[6-9]/AGMC/Academic/IEC Committee/2015/8965, dated 25 April 2018) and International Centre for Genetic Engineering and Biotechnology, New Delhi (ICGEB/IEC/2017/07).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors. ER -